ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,143.09
-0.07%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Viking Therapeutics Inc (VKTX)

  7. Viking Therapeutics Inc (VKTX) Noticias

VKTX Viking Therapeutics Inc

52.07
-0.03 (-0.06%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Viking Therapeutics Inc VKTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.03 -0.06% 52.07 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
51.08 48.20 52.85 52.02 52.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/6/202406:10EDGAR2Form 8-K - Current report
04/6/202406:05PRNUSViking Therapeutics Announces Positive 52-Week Histologic..
30/5/202415:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
22/5/202416:12EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/5/202415:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
24/4/202415:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
24/4/202406:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
17/4/202415:05PRNUSViking Therapeutics to Report Financial Results for First..
26/3/202406:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
04/3/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:52EDGAR2Form 8-K - Current report
04/3/202415:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
01/3/202415:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202419:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
27/2/202416:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202415:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
27/2/202406:04EDGAR2Form 8-K - Current report
27/2/202406:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
09/2/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:01EDGAR2Form 144 - Report of proposed sale of securities
08/2/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:56EDGAR2Form 144 - Report of proposed sale of securities
08/2/202415:33EDGAR2Form 144 - Report of proposed sale of securities
07/2/202416:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/2/202416:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202415:09EDGAR2Form 8-K - Current report
07/2/202415:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
31/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:32EDGAR2Form 144 - Report of proposed sale of securities
31/1/202415:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
30/1/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:23EDGAR2Form 144 - Report of proposed sale of securities
19/1/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:36EDGAR2Form 144 - Report of proposed sale of securities
04/1/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202420:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202420:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
02/11/202315:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
25/10/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/10/202315:24EDGAR2Form 8-K - Current report
25/10/202315:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
23/10/202306:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
18/10/202315:05PRNUSViking Therapeutics to Report Financial Results for Third..
18/10/202308:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
18/10/202308:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
17/10/202315:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
10/10/202315:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..

Su Consulta Reciente

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados